Background/Objective: Ferroptosis is an iron-dependent form of programmed cell death characterized by lipid peroxidation products (LPOs). A chemotherapeutic drug, 5–fluorouracil (5–FU), can induce epithelial mucositis and favor drug synergism with erastin in ferroptosis. Camellia tea saponin extract (TS) is known to exert antioxidative properties. This study aims to delineate the protective role of TS in mitigating 5–FU-induced ferroptosis and inflammation in human keratinocytes. Methods: HaCaT cells were induced by 5–FU and erastin, treated with different TS doses, and their viability was then determined. Levels of cellular reactive oxygen species (ROS), LPOs, labile iron pool (LIP), glutathione (GSH), glutathione peroxidase 4 (GPX–4) activity, as well as IL–6, IL–1β, and TNF–α levels, and their wound healing properties were assessed. Results: TS per se (at up to 25 µg/mL) was not toxic to HaCaT cells but was unable to restore the viability of 5–FU-induced cells up to the baseline levels. The compound significantly diminished increases in cellular ROS, LPOs, and LIP, while restoring GSH content and GPX–4 activity. Additionally, it suppressed the cytokine production of 5–FU-induced cells in a concentration–dependent manner. Moreover, TS exerted wound-healing effects against skin injuries and 5–FU damage significantly and dose dependently. Conclusions: The insights of this work have identified biochemical mechanisms using tea saponin extract to protect against 5–FU-induced keratinocyte ferroptosis and inflammation. This study highlights the promising adjunctive potential of tea saponin in the mitigation and management of chemotherapy-induced mucositis.
The use of saponins with biosurfactant, antioxidant, anti-inflammatory, and anti-cancer properties is limited by their toxicity and bioavailability. This study focused on the fabrication, characterization, and bioactivity of crude tea saponin (TS) and TS-incorporated silica nanoparticles (TSNPs). Our results showed that TS contained seven saponins and that TSNPs had an average diameter of 200–300 nm, a negative surface charge, and high polydispersity. Fourier Transform Infrared Spectroscopy (FTIR) revealed an incorporation bond of Si-O- and -OH controlling releasing behavior with t50 = 24 h. Using HaCaT cells, it was demonstrated that TSNPs reduced cytotoxicity. Reactive oxygen species (ROS) production was lowered in both TS and TSNP treatments, with significantly greater efficacy at higher concentrations. Additionally, TSNPs significantly accelerated cell migration in the wound closure model as efficiently as TGFβ. Together, these findings offer promising TSNPs for biomedical applications and therapeutic agents due to their antioxidant properties, cytotoxicity protection, and wound closure acceleration.